 |
|
Biotage AB launches share buy-back
Resolutions at the Annual General Meeting in Biotage AB on April 25, 2013
Interim report January - March 2013
|
|
| |
Company Overview
| Biotage® offers solutions, knowledge and experience in the areas of analytical chemistry and medicinal chemistry. Customers include the world’s largest pharmaceutical and biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has offices in the US, UK, Japan and China. Biotage has 272 employees with sales of 428.9M SEK in 2010. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. |
 |
Aim The group aims to accelerate the drug discovery and development process, and to increase knowledge by providing complete solutions for Medicinal and Analytical Chemistry and Process Development. The company aims to be market leading in each of its niche areas.
Customers The company has a strong customer base of industry and academic partners, which include the world’s top 20 pharmaceutical companies and prestigious academic institutes such as the US National Institutes of Health, the US Centers for Disease Control and Prevention and the Karolinska Institute in Sweden.
The Executive Committee
 |
|
 |
|
 |
Torben Jørgensen President & CEO |
|
Erika Söderberg Johnson CFO |
|
Lars Bäckman VP of Corporate Development |
Management and Board »
Locations Headquartered in Uppsala, Sweden, Biotage AB also has facilities in Lund, Sweden; Charlotte, NC; Cardiff, UK, Tokyo, Japan, and Shanghai, China.
|
|
|
| |
Print page
|
|
 |
| |
|
|
|